3357-0452 Screening compound: 4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}benzamide

3357-0452 Screening compound: 4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}benzamide
3357-0452 Screening compound: 4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3357-0452
4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3357-0452

Molecular Formula

C20H21ClN4O2 (C20 H21 ClN4 O2)

Compound Name

4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-1,3-benzodiazol-2-yl}benzamide

IUPAC name

4-chloro-N-{1-[2-(morpholin-4-yl)ethyl]-1H-13-benzodiazol-2-yl}benzamide

SMILES

O=C(c(cc1)ccc1Cl)Nc1nc(cccc2)c2n1CCN1CCOCC1

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

384.87

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.248

Distribution Coefficient, logD

3.177

Water Solubility, LogSw

-3.88

Polar Surface Area

47.035

Acid Dissociation Constant (pKa)

9.70

Base Dissociation Constant (pKb)

6.64

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.00

3357-0452 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Angiogenesis library (14822 compounds)

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Nucleic Acid Ligands (8311 compounds)

PI3K-Targeted Library (17255 compounds)

STING Agonist Library (5895 compounds)

Selective Target Activity Profiling Library (14702 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Infections
  • Cancer
  • Musculoskeletal
  • Nervous system
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Immune system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • GPCR
  • Ion Channels
  • Kinases
  • Others
  • Kinases

References: we are preparing a list of scientific research reports with 3357-0452 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3357-0452?
Check Price and Availability of 3357-0452, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3357-0452 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3357-0452
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3357-0452
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3357-0452 available by request